Lifetime health and economic consequences of obesity

Archives of Internal Medicine

Volumn 159, Issue 18, 1999, Pages 2177-2183

  Thompson, David ^a,b   Edelsberg, John ^a   Colditz, Graham A ^a   Bird, Amy P ^a   Oster, Gerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b POLICY ANALYSIS INC PAI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

ADULT; AGE FACTORS; BODY MASS INDEX; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE EXPECTANCY; MALE; MIDDLE AGED; MODELS, STATISTICAL; OBESITY; RISK; SEX FACTORS; UNITED STATES;

EID: 0033547217     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.18.2177     Document Type: Article

References (25)

1. Kuczmarski RJ, Flegel KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-211.
2. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655-660.
3. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
4. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486.
5. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995;141:1117-1127.
6. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6:97-106.
7. Oster G, Colditz GA, Kelly NL. The Economic Costs of Smoking and Benefits of Quitting. Boston, Mass: DC Heath & Co; 1984.
8. Oster G, Colditz GA, Kelly NL. The economic costs of smoking and the benefits of quitting for individual smokers. Prev Med. 1984;13:377-389.
9. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q. 1992;70:81-125.
10. Wolf AM, Colditz GA. The cost of obesity: the US perspective. Pharmacoeconomics. 1994;5(suppl 1):34-37.
11. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-1258.
12. US Department of Health and Human Services (DHHS), National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Adult, Exam, and Laboratory Data Files [CD-ROM]. Hyattsville, Md: Centers for Disease Control and Prevention; 1996. Public Use Data File Documentation 76200. Available from the National Technical Information Service (NTIS), Springfield, Va.
13. National Institutes of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health; 1995.
14. Odell TW, Gregory MC. Cost of hypertension treatment. J Gen Intern Med. 1995; 10:686-688.
15. Oster G, Borok GM, Menzin J, et al. Cholesterol-Reduction Intervention Study (CRIS): a randomized trial to assess effectiveness and costs in clinical practice. Arch Intern Med. 1996;156:731-739.
16. Huse DM, Oster G, Killen AR, et al. The economic costs of noninsulin-dependent diabetes mellitus. JAMA. 1989;262:2708-2713.
17. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study 18-year follow-up. In: Kannel WB, Gordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, DC: US Government Printing Office; 1974. Department of Health, Education, and Welfare publication (National Institutes of Health) 74-599.
18. Petty GW, Brown RD, Whisnant JP, et al. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975-1989. Neurology. 1998;50:208-216.
19. National Center for Health Statistics. Vital Statistics of the United States, 1992, Vol II, Mortality, Part B. Washington, DC: Public Health Service; 1996.
20. Oster G, Huse DM, Lacey MJ, Epstein AM. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients. Stroke. 1994;25:1149-1156.
21. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207-2212.
22. Stampfer MJ, Maclure KM, Colditz GA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652-658.
23. Felson DT, Anderson JJ, Naimark A, et al. Obesity and knee osteoarthritis: the Framingham study. Ann Intern Med. 1988;109:18-24.
24. Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast cancer and endometrial cancers. Am J Clin Nutr. 1996;63(suppl):437S-441S.
25. Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body mass index and mortality. N Engl J Med. 1998;338:1-7.